BeOne Medicines (BEIGF) Shares Outstanding (Diluted Average) (2017 - 2020)
BeOne Medicines (BEIGF) reported Shares Outstanding (Diluted Average) of $1.0 billion for Q1 2020, up 67.39% quarter-over-quarter from $600.6 million in Q3 2017.
BeOne Medicines (BEIGF) Shares Outstanding (Diluted Average) (2017 - 2020) Analysis & Trends
BeOne Medicines (BEIGF) has 2 years of Shares Outstanding (Diluted Average) data on file, last reported at $1.0 billion in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 810.00 |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | 118.76 Bn |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | 92.44 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 1.01 Bn |
| Sep 30, 2017 | 600.61 Mn |